102 Alternatively, various teams are advocating to the incorporation of novel markers, like a advanced karyotype55 or epigenetic subsets, 27,28 into clinical practice. All these novel prognostic and/or predictive versions will have to be validated in cohorts of patients addressed with specific agents.Richter transformation remains an ominous functi